CZChengyun Zhang

Chengyun Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chengyun Zhang has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    HighFold4: extending AlphaFold3 to accurate cyclic peptide conformation prediction via custom chemical connectivity

    by Chengyun Zhang, Wentong Wang, Renjie Zhu, Sen Cao, Yiqi Xu, Ning Zhu, Yaling Wu, Jingjing Guo, Hongliang Duan

    While AlphaFold3 has revolutionized protein structure prediction and supports noncanonical amino acids, its architecture always fails to reliably generate the closed-ring topologies characteristic of cyclic peptides. Existing adaptations, such as imposing distance constraints via an offset matrix, enforce ring geometry but cannot specify the chemical identity of the cyclization bond, leading to a restrictive bias toward amide- or disulfide-linked macrocycles. Here, we present HighFold4, a framework that adapts AlphaFold3 to explicitly incorporate user-defined chemical connectivity between residues, thereby enabling both topological closure and bond-specific cyclization. Without retraining the base model, HighFold4 achieves accurate, chemistry-aware prediction of diverse cyclic peptide conformations, as validated on 179 structures. This work established a new paradigm for the conformation construction of macrocyclic peptides with tailored ring geometry and linkage chemistry, significantly expanding the utility of deep learning in peptide-based drug discovery.


  • HighMorph: De Novo Cyclic Peptide Sequence Design via Protein–Protein Interaction Recapitulation

    by Minhui Lan, Chengyun Zhang, Wentong Wang, Haomeng Hu, Huitian Lin, Sen Cao, Jingjing Guo, Hongliang Duan

    Cyclic peptides have emerged as a compelling class of bioactive scaffolds, but de novo design of target-binding cyclic peptides from protein structures remains challenging. Here, we present HighMorph, an interaction-guided framework that combines protein–protein interaction information with artificial intelligence for rational cyclic peptide design. HighMorph integrates Monte Carlo tree search with a Transformer-based policy-value network to efficiently explore cyclic peptide sequence space, while incorporating explicit atomic-level hydrogen bond constraints extracted from reference protein–protein complexes to guide sequence optimization. The framework is systematically validated on two clinically relevant targets, programmed death-ligand 1 (PD-L1) and kallikrein-related peptidase 4 (KLK4). Notably, 33.3% and 40% of the generated candidates are active against PD-L1 and KLK4, respectively, with active cyclic peptides exhibiting micromolar binding affinities (approximately 10–6 M). These results validate our approach for cyclic peptide design. Additionally, interaction analysis provides insights for developing therapeutics targeting challenging protein interfaces.

  • Open Access

    HighRes_Builder: improved access and modeling of noncanonical residues for protein structure prediction

    by Yanchao Han, Jianfeng Mei, Gaoshuai Li, Enkang Dai, Hanlei Lu, Chengyun Zhang, Yanlu Zhang, Chenshui Lin, Chuanlong Zeng, Hongliang Duan, et al.

    The growing support for noncanonical amino acids in structure prediction tools such as AlphaFold3 has been largely facilitated by the Chemical Component Dictionary (CCD). However, the limited coverage of modified residues in CCD continues to restrict the application of these models to many biologically and therapeutically relevant peptides. To address this gap, we present HighRes_Builder, a computational method for efficient residue search and automated construction of noncanonical amino acids not currently archived in CCD. We demonstrate the utility of our approach by predicting structures for 3179 noncanonical residues beyond the CCD using AlphaFold3. AlphaFold3 achieved 100% acceptance for both the noncanonical residue monomers and their corresponding ‘GGXGG’ motifs (where X denotes the noncanonical residue). Of these, 72.44% of the predicted residue monomer structures concurrently satisfy all five geometric criteria (d_N_C1, d_Ck_Ccarb, d_Ccarb_O_mean, ang_Ck_Ccarb_O_mean, and ang_O1_Ccarb_O2). Furthermore, among the generated motif structures, 85.78% exhibited favorable ω values for the embedded noncanonical residues. Furthermore, by integrating HighRes_Builder with structure prediction systems, AlphaFold3 for linear peptides and HighFold3 for cyclic peptides, we successfully model the conformation of the linear peptide drug Relamorelin and the cyclic therapeutic peptides LUNA18 and JNJ-77242113 in complex with their target proteins, elucidating structural determinants of their mechanism of action. This work establishes a scalable and accurate framework for structure prediction of diverse nonstandard peptides, highlighting its potential to accelerate rational design of peptide-based therapeutics.


  • HighFold-MeD2: An Enhanced Boltz-2 Model for Accurate Structure Prediction of N-Methylated and d -Amino Acid Cyclic Peptides

    by Zhigang Cao, Wentong Wang, Sen Cao, Chengyun Zhang, Jingjing Guo, Hongliang Duan

    Cyclic peptides containing backbone N-methylated amino acids (BNMeAAs) and d-amino acids (d-AAs) exhibit exceptional metabolic stability, membrane permeability, and oral bioavailability, representing a pivotal middle space scaffold between biologics and s small-molecule drugs. To optimize pharmacokinetic and physicochemical properties, various non-canonical amino acids(NCAAs) are frequently introduced; however, these modifications pose significant challenges for three-dimensional structure prediction. While Rosetta simple_cycpep_predict (SCP) can generate high-accuracy structures across a broad chemical space based on energy functions, it requires extensive conformational sampling, resulting in prohibitive computational costs. Recently, deep learning approaches such as AlphaFold3, Boltz-2, HighFold2, and NCPepFold have advanced cyclic peptide prediction but offer limited support for BNMeAAs and d-AAs. In previous work, HighFold-MeD was proposed, which distilled massive conformational data generated by Rosetta SCP into the AlphaFold2 framework, significantly accelerating prediction for modified cyclic peptides. Building upon this, the present study introduces HighFold-MeD2, an enhanced model based on Boltz-2. By leveraging the sequence, modification information, and cyclic constraints as inputs, HighFold-MeD2 utilizes the Pairformer-Diffusion architecture of Boltz-2 to learn the generation of all-atom coordinates from random initialization to Rosetta target structures. The predicted structures are subsequently refined via Amber force field energy minimization to resolve local steric clashes. Unlike its AlphaFold2-based predecessor, which relied on labor-intensive hard-coding for non-natural amino acids, HighFold-MeD2 achieves seamless integration through universal Chemical Component Dictionary (CCD) representations. It not only demonstrates superior prediction precision over HighFold-MeD and state-of-the-art baselines but also validates the feasibility of utilizing CADD-generated conformations to fine-tune all-atom diffusion models, establishing a highly accessible and extensible paradigm for cyclic peptide drug design.

  • HighMPNN: A Graph Neural Network Approach for Structure-Constrained Cyclic Peptide Sequence Design

    by Wen Xu, Chengyun Zhang, Tianfeng Shang, Qingyi Mao, Jingjing Guo, Hongliang Duan

    Cyclic peptides become attractive therapeutic candidates due to their diverse biological activities. However, existing deep learning-based sequence design models, such as ProteinMPNN, are primarily intended for linear peptides or proteins and do not explicitly account for the unique topological constraints of cyclic peptides. In this study, we introduce HighMPNN, a graph neural network model specifically developed for cyclic peptide sequence design. Through the integration of explicit structural constraints into the GNN-based framework, HighMPNN captures the geometric features of cyclic backbones while learning sequence patterns. The combination of cross-entropy loss with Frame Aligned Point Error (FAPE) loss allows the model to simultaneously optimize sequence generation and enhance structural accuracy. HighMPNN demonstrates superior performance in both sequence recovery rate and structural consistency compared to baseline models, achieving an average sequence recovery rate of 63.95% and an average Cα root-mean-square deviation (RMSD_Cα) of 1.413 Å. These results highlight the model's ability to generate sequences that closely resemble native backbones. At present, HighMPNN is limited to natural amino acids. Future work will focus on extending the framework to support non-canonical residues and structurally diverse cyclic peptide scaffolds, thereby accelerating cyclic peptide discovery and advancing peptide-based drug development.


  • High-PepBinder: A pLM-Guided Latent Diffusion Framework for Affinity-Aware Target-Specific Peptide Design

    by Qingyi Mao, Silong Zhai, Sen Cao, Renjie Zhu, Wen Xu, Chengyun Zhang, Ning Zhu, Jingjing Guo, Hongliang Duan

    Peptides, as therapeutic molecules, offer unique advantages in targeting complex protein surfaces, yet their rational design remains limited by the vastness of the sequence space and the constraints of traditional approaches. Here, we propose High-PepBinder, a sequence-only conditional diffusion framework for target-specific peptide generation. Guided by the target protein sequence, High-PepBinder adopts a dual encoder architecture that integrates protein language models (pLMs) with the diffusion model. This approach cascades the peptide generation model with an affinity classifier and enables the generation process to capture affinity-related features of the peptides through lightweight joint optimization. Due to the scarcity of protein-peptide affinity data, we constructed PepPBA, to our knowledge, the most comprehensive dataset to date, and established a structure- and physics-based screening pipeline to prioritize top candidates. Results show that High-PepBinder demonstrates competitive performance across multiple peptide generation and binding-related evaluation tasks. For representative targets, including KEAP1, XIAP and EGFR, the generated peptides preserve key binding geometries and interface patterns of reference peptides in predicted complexes, while maintaining sequence diversity and favorable predicted properties. Overall, High-PepBinder contributes toward a general and sequence-only strategy for peptide design, offering a computational framework for expanding peptide discovery against challenging targets.


  • HighRelax: Physics-Based Refinement of Deep Learning Protein Predictions with Noncanonical Amino Acids

    by Sen Cao, Chengyun Zhang, Ning Zhu, Chongyang Li, Qingyi Mao, Zhigang Cao, Yutong Ge, Yaling Wu, Juan Guo, Qiang Cao, et al.

    Noncanonical amino acids (NCAAs) have emerged as essential building blocks in protein engineering and peptide drug development owing to their advantages in enhancing metabolic stability, membrane permeability, and resistance to proteolytic degradation. Accurate construction of 3D protein structures containing NCAAs is crucial for elucidating their functions, understanding molecular interactions, and enabling rational design. However, integrating NCAAs into state-of-the-art protein structure prediction frameworks─such as AlphaFold3─often results in chirality violations, steric clashes, and local geometric distortions. These issues likely reflect limited parametrization of nonstandard residues within current models. To address these challenges, we expanded the AMBER force field covering 139 NCAAs, and we developed an enhanced Amber-relax protocol named HighRelax. Unlike conventional workflows that are restricted to linear peptides composed of canonical amino acids, HighRelax is compatible with complex systems containing NCAAs and cyclic peptides and can be seamlessly integrated with structures generated by state-of-the-art models such as AlphaFold3. Our results demonstrate that HighRelax effectively reduces steric clashes, restores residue chirality, and improves overall structural quality. This method provides a general postprocessing strategy for refining NCAA-containing structures, facilitating their applications in molecular simulation, peptide drug design, and protein engineering.


  • Open Access

    High-PepBinder: A pLM-Guided Latent Diffusion Framework for Affinity-Aware Target-Specific Peptide Design

    by Qingyi Mao, Silong Zhai, Sen Cao, Renjie Zhu, Wen Xu, Chengyun Zhang, Ning Zhu, Jingjing Guo, Hongliang Duan

    Peptides, as therapeutic molecules, offer unique advantages in targeting complex protein surfaces, yet their rational design remains limited by the vastness of the sequence space and the constraints of traditional approaches. Here, we propose High-PepBinder, a sequence-only conditional diffusion framework for target-specific peptide generation. Guided by the target protein sequence, High-PepBinder adopts a dual encoder architecture that integrates protein language models (pLMs) with the diffusion model. This approach cascades the peptide generation model with an affinity classifier and enables the generation process to capture affinity-related features of the peptides through lightweight joint optimization. Due to the scarcity of protein-peptide affinity data, we constructed PepPBA, to our knowledge the most comprehensive dataset to date, and established a structure- and physics-based screening pipeline to prioritize top candidates. Results show that High-PepBinder demonstrates competitive performance across multiple peptide generation and affinity-related tasks. For representative targets, including KEAP1, XIAP, and EGFR, the generated peptides preserve key binding geometries and interface patterns of reference peptides in predicted complexes, while maintaining sequence diversity and favorable predicted properties. Overall, High-PepBinder contributes toward a general and sequence-only strategy for peptide design, offering a computational framework for expanding peptide discovery against challenging targets.


  • Open Access

    HFGuidedDesign: de novo design of cyclic peptide binders via structure-guided discrete diffusion

    by Haomeng Hu, Renjie Zhu, Ning Zhu, Chengyun Zhang, Tianfeng Shang, Chongyang Li, Jingjing Guo, Xudong Wang, Hongliang Duan

    HFGuidedDesign integrates discrete diffusion with HighFold-guided structural feedback to generate cyclic peptide binders from protein sequences, followed by synthesis and SPR validation.


  • AlphaFold3 for Noncanonical Cyclic Peptide Modeling: Hierarchical Benchmarking Reveals Accuracy and Practical Guidelines

    by Chengyun Zhang, Wentong Wang, Ning Zhu, Zhigang Cao, Yaling Wu, Qingyi Mao, Cheng Zhu, Chenhao Zhang, Jingjing Guo, Hongliang Duan

    Despite the revolutionary impact of AlphaFold3 on structural biology, this model's capability in predicting noncanonical cyclic peptides remains unexplored. Given the clinical significance of cyclic peptides containing unnatural residues as a therapeutic modality, we present the first systematic evaluation of AlphaFold3 for this class of molecules. To facilitate benchmarking, we developed an automated input pipeline to streamline AlphaFold3 predictions for cyclic peptides. Our study aims to (1) quantify the hierarchical accuracy (all atoms, Cα atoms, and atoms of unnatural residue levels) of AlphaFold3 in predicting both noncanonical cyclic peptide monomers and complexes, (2) assess the reliability of AlphaFold3's confidence metrics, (3) evaluate the influence of multiple sequence alignment and structural templates, and (4) identify systematic biases in AlphaFold3's predictions. Based on these analyses, we provide practical guidelines for applying AlphaFold3 in cyclic peptide structure prediction to facilitate the related research of bioactive cyclic peptides.